Human Tissue Pharmacology
Preclinical and Drug Discovery CRO
REPROCELL Biopta’s human tissue technology predicts clinical success by using the closest possible model of drug behavior in humans.
Human tissue testing is a translational approach to drug discovery that bridges the gap between animal studies and clinical trials — increasing clinical success rates and adding commercial value to preclinical drug assets through proof of concept in patient-derived living tissues.
REPROCELL Biopta® — the human tissue experts
Trusted by top Pharma
Drug discovery assay catalog
REPROCELL Biopta is home to the world’s first and largest human fresh tissue assay catalog. In this digital platform, you can filter our assays by tissue type, endpoint, receptor, platform technology, drug type, and more.
Alvetex® bioengineered 3D tissue services
Complementing our fresh tissue assays by accurately recreating human biology in bioengineered tissues.
Human tissue assay types
This invaluable information allows you to make ‘go’ or ‘no-go’ decisions with greater confidence, based on human data generated in fresh biospecimens sourced from the target patient population or in bioengineered human tissues.
Examples of our work
Our expertise in all areas of human tissue testing – including ethics, sourcing, handling, and fee-for-service experiments in human fresh tissue – allows us to act as your human tissue research department.
Why use human tissue?
Managing risks and saving money in drug discovery
Human fresh tissue can be used to manage risk and save money across the entire drug discovery pipeline.
Demonstrating efficacy and safety at every phase of drug discovery
Human fresh tissue can be used in all phases of drug discovery programs, from target validation to clinical trouble shooting.
Our human tissue platform technologies
At REPROCELL, we offer a unique range of experimental techniques for translating data from preclinical species to humans.
Join our human tissue supplier network
We are investing in our tissue network to meet the growing safety and efficacy requirements of drug development programs and medicine regulators around the globe.
On the REPROCELL blog
Latest in Drug Discovery
Key Strategies Central Labs Use to Fast-Track Time to Market
Learn how central labs use automation, outsourcing, and AI to accelerate drug development, reduce costs, and improve clinical trial accuracy and efficiency.
18 November 2024
REPROCELL's Advanced Skin Tissue Engineering
Discover REPROCELL's pioneering 3D skin tissue engineering, enhancing drug development and skincare research with accurate and robust human skin models.
31 October 2024
Discover the differentiation potential of induced pluripotent stem cells (iPSC) to cytotoxic NK cells, including recent advancements in research and therapy.
16 October 2024
The Power of Human Tissue Models in Preclinical Research
Discover how human tissue models are transforming drug safety assessments and improving outcomes in preclinical research through real-world case studies.
03 October 2024
Understanding Safety Pharmacology in Human Tissues
Explore the role of safety pharmacology in drug discovery, and the importance of human tissue studies for predicting and mitigating potential effects.
26 August 2024